Depending on their interaction with intracellular proteins, G protein-coupled receptors (GPCR) often display different affinities for agonists at 378C. Determining the affinity at that temperature is often difficult in intact cells as most GPCRs are internalized after activation. When sequestration of the B 2 bradykinin receptor (B 2 R) was inhibited by either 0.5 M sucrose or phenylarsine oxide (PAO), a shift in the affinity was detected when the incubation temperature was raised from 48C to 378C or lowered from 378C to 48C. In contrast, binding of the antagonist w 3 HxNPC 17731 was temperature-independent. B 2 R mutants displayed different affinity shifts allowing conclusions on the role of the involved amino acids. By inhibiting receptor sequestration it was possible to determine also dissociation of w In summary, our data demonstrate that inhibition of receptor internalization either by PAO or sucrose provides an excellent method to study receptor function and the effects of mutations in intact cells.
Introduction
The family of the G protein-coupled receptors (GPCRs) represents one of the largest groups with more than a thousand members identified in the mammalian genome (Gether, 2000; Pierce et al., 2002) . Their name derives from their ability to recruit intracellular heterotrimeric G proteins when stimulated by an extracellular agonist. They play a pivotal role in the perception of the environment because light and odor are sensed in higher organisms via members of this receptor family. They are also involved in the control of physiology and behavior as indicated by the immense chemical diversity of their endogenous ligands. Therefore deeper insight into the mechanisms by which these GPCRs are regulated and how they mediate extracellular signals through the membrane into the cell is of highest interest. Advanced knowledge of the structure/function relationship of GPCRs as well as of useful differences between the various family members is indispensable for the development of better and more specific drugs to interfere with their signal transduction.
One characteristic property of GPCRs is that most of them respond in crude membrane preparations to the addition of GTP at higher temperatures ()258C) with a shift to lower affinity for agonists but usually not for antagonists. The extent of the shift that can be observed with different GPCRs varies markedly from no shift at all (AT 2 angiotensin receptor, Zhang and Pratt, 1996 ; B 1 bradykinin receptor, Faussner et al., 1999) , to 3-10 fold reductions for some peptide receptors (AT 1 angiotensin receptor, Hunyady et al., 1995 ; B 2 bradykinin receptor, Faussner et al., 1998) to 50-100 fold, e.g. for the A 2A adenosine (Murphree et al., 2002) or the b-adrenergic receptor (Schwarz et al., 1986; Rasenick et al., 1994) . Despite this variance and sometimes even its absence, this shift in response to GTP addition is considered a landmark of GPCRs because according to the currently accepted models of receptor regulation it reflects the coupling to (high affinity state) or uncoupling from (low affinity state) their cognate G protein(s). It has, however, been reported that not only heterotrimeric G proteins but also other intracellular proteins, e.g. small G proteins or arrestins, can influence the affinity of a GPCR (Gurevich et al., 1997; Mitchell et al., 1998) .
In order to determine a shift in affinity usually (crude) membrane preparations have to be prepared and the dissociation constant K d has to be determined with a radiolabeled agonist in the presence or absence of GTP. In many cases, the assay has to be conducted at temperatures lower than 378C, because otherwise no shift can be detected. Alternatively, using a suitable radiolabeled antagonist, a right-shift in the competition curves of the unlabeled agonist after addition of GTP can indicate an affinity shift. The latter is applicable mostly for receptors that show a strong shift. The determination of the shift in intact cells is in many cases hampered by the fact that the majority of the GPCRs respond to agonist stimulation with rapid sequestration of the receptors from the cell surface (Koenig and Edwardson, 1997) . Correct measurement of the K d is, therefore, impossible, as binding at equilibrium is a prerequisite.
The B 2 bradykinin receptor (B 2 R) belongs to the class A, the rhodopsin/b 2 -adrenergic-like GPCRs (Fredriksson et al., 2003) , and mediates the effects of the hormones bradykinin (BK) and kallidin (Regoli et al., 2001 ). These short peptides (nine and ten amino acids, respectively) are released from their high-molecular weight precursors, the kininogens, through the action of specific enzymes, the kallikreins (Clements et al., 2001) . Stimulation of the B 2 R results in vasodilatation, edema formation, and induction of pain (Proud, 1988) .
We have previously shown that the B 2 R in intact human fibroblast as well as in crude membrane preparations when kept 48C on ice is apparently in a high affinity state. In crude membranes this high affinity state was also quite stable at 378C, but could be reduced to lower affinity by addition of GTP or GDP (Faussner and Roscher, 2000) .
When we observed in intact cells that poorly internalizing B 2 R mutants (Faussner et al., 1998) still exhibited a significant drop in surface binding activity when the temperature was raised from 48C to 378C, we set out to investigate whether this observation was caused by a shift in the receptor affinity and if so, how this effect could be used to study the binding behavior and signaling of internalizing wild-type receptor and receptor mutants in intact cells.
Results

Poorly internalizing B 2 R mutant displays decreased binding activity at 378C
A B 2 R mutant (G327stop) lacking the C-terminal tail due to insertion of a stop codon after glycine 327 (Faussner et al., 1998) was preincubated at 48C with w 3 HxBK and then warmed up to 378C in order to start ligand internalization. A clear reduction in surface binding was observed that reached a plateau within 5 min. This reduction was seen despite the poor ligand internalization, suggesting that this effect is unlikely caused by sequestration of the receptor. As the internalization rate is usually calculated as internalized w 3 Hxligand in percentage of the combined amount of internalized and surface bound w 3 Hxligand, a reduction in surface binding leads to an apparently increased ligand internalization (inset Figure 1 ) even when absolute ligand internalization (Figure 1 ) is slow. This drop in total binding can of course be observed only when the internalization process is started at 378C after reaching the binding equilibrium at 48C, and not when the w 3 Hxagonist is added directly at 378C. Similar results were obtained with G327stop expressed in Chinese hamster ovary cells, indicating that this effect does not depend on the cell type.
Inhibition of receptor sequestration reveals reduced surface binding also in wt B 2 R Next we investigated whether the observed reduction in surface binding is due to a loss in receptor number, i.e. part of the receptors becoming inactive for binding, or due to a defined shift of the receptor affinity occurring when the incubation temperature is raised from 48C to 378C. Moreover, it should be clarified whether this reduction is a general property of the wt B 2 R or solely of the mutant G327stop lacking the C-terminal domain. Due to the fast internalization of the wt B 2 R reduction of surface binding is generally considered to be a consequence of receptor sequestration. An accompanying receptor inactivation or affinity shift would be noticed only after inhibition of the receptor internalization.
Therefore, we applied two common methods to prevent B 2 R sequestration: firstly, the hyperosmolaric method with addition of 0.5 M sucrose in the incubation medium (Heuser and Anderson, 1989 ) is supposed to disrupt the clathrin-coat of certain vesicles, thereby inhibiting receptor sequestration. This method, however, may affect also receptor sequestration which does not involve clathrin-coated pits via so far unknown mechanisms (Roseberry and Hosey, 2001) .
Secondly, we used preincubation of the cells for 5 min at 378C with 100 mM phenylarsine oxide (PAO; Hertel et al., 1985) . Both treatments effectively prevented the internalization of w 3 HxBK (Figure 2A, B) by the wt B 2 R. Less than 20% (0.5 M sucrose, Figure 2A ) and even less than 10% (100 mM PAO, Figure 2B ) of totally bound w 3 HxBK became internalized after 30 min at 378C. However, despite this inhibition of ligand internalization, a reduction in surface binding was observed with both treatments resulting in a plateau after 5-10 min. Because the PAO preincubation evoked a stronger inhibition and is easier to perform, it HxBK was determined as described in the materials and methods section. The determinations were performed in triplicates and are given as mean"SD. Each experiment was conducted at least three times with similar results. HxBK at 378C with (s) or without (n) by an additional incubation on ice for 90 min. Control cells (d) were incubated on ice only. Each value is the mean of duplicates. Regression analysis resulted in the following equilibrium constants K d s2.8"0.17 nM (378C), 9.7"0.15 nM (378C™48C), and 3.5"0.18 nM (48C). Each experiment was repeated at least twice with similar results. became our preferred method for inhibiting receptor sequestration. Other (pre)treatments of the cells either with N-methyl-maleimide (1 mM, 5 min/378C) or digitonin (20 mg/ml, 5 min/378C) also strongly inhibited ligand internalization of the wt B 2 R and resulted in identically reduced binding activity at 378C.
Reduction of surface binding at 378C is due to a reversible shift in affinity
Equilibrium binding and subsequent Scatchard analysis of the data revealed that the binding reduction as a consequence of the raise of the incubation temperature from 48C to 378C is not due to a loss of receptors, but is rather caused by a shift in the receptor affinity for w 3 HxBK ( Figure  3A ). This shift is not an artifact provoked by increased w 3 HxBK degradation at 378C, because it can also be observed in the reverse direction: while the binding curves of cells incubated at 378C indicate a lower receptor affinity ( Figure 3B ), the binding curves become almost identical after an additional incubation on ice to those of cells that have been placed on ice immediately. The receptor affinity at 48C after PAO pre-treatment was identical to that of control cells which were not treated with PAO (not shown), suggesting that PAO does not affect those parts of the receptor that are directly involved in ligand binding. The temperature change influenced only the binding of the agonist w 3 HxBK, but not that of the antagonist w 3 HxNPC 17731 (cf. Figure 5B ).
Different affinity shifts occur in wt B 2 R and receptor mutants
Next we wanted to compare the temperature-induced affinity shifts of wt B 2 Rs with high (10.4 pmol/mg protein) and lower (4.4 pmol/mg protein) expression with that of different receptor mutants (see Table 1 ). One of these mutants was the construct Y305A, in which the tyrosine in the highly conserved NPXXY sequence located at the end of the 7 th transmembrane segment was exchanged by an alanine. This mutant was of particular interest, because we had shown recently that it is precoupled to G protein G q/11 even in the absence of an agonist (Kalatskaya et al., 2004) . A reason for this behavior might be that Y305A displays a persistent high affinity conformation. The second mutant, termed E177A, was of interest as the mutated glutamate at position 177 should play a role in high affinity binding of w 3 HxBK (Kyle et al., 1994; Jarnagin et al., 1996) . The third construct carried both mutations (mutant E177A/Y305A).
The high and low expressed B 2 Rs exhibited a slightly different affinity, however, in both cases a clear temperature-dependent shift was obvious (see Table 1 ). In contrast, mutant Y305A revealed a tendency to higher affinity at 378C instead of exhibiting a shift to lower affinity. This result suggests that the mutation of the tyrosine in the NPXXY sequence indeed induces a receptor conformation that permanently displays a high affinity. Mutant E177A displayed a complete different behavior than construct Y305A. Already at 48C its affinity was approximately 6 times lower than that of the wt B 2 Rs suggesting that glutamate 177 is directly involved in binding. At 378C its affinity was reduced to such an extent that it could only be estimated as being )200 nM under the assumption that the reduction in binding was not due to a loss in receptors. That this assumption is justified was indicated by the fact that the high affinity binding could almost completely be recovered by a subsequent incubation on ice (not shown), similarly as demonstrated before for the wt B 2 R (cf. Figure 3 ). This strong affinity shift might be a combination of two independent effects, the reduced binding affinity caused by changing an amino acid involved in ligand binding and the affinity reduction due to a conformational change induced by activation of the receptor mutant. This notion is supported by the affinity shift observed for the double mutant E177A/Y305A that also exhibited a reduced affinity at 48C as compared to the wt B 2 Rs, but a distinctly lesser reduced affinity at 378C (cf. Table 1 ). This was most likely because the reduction component caused by the conformational change is blocked by the second mutation of tyrosine Y305 to alanine. These results suggest that glutamate 177 is important solely for high affinity binding of BK but is not directly involved in the activation of the B 2 receptor.
Temperature dependence of the affinity shift varies in wt B 2 R and the selected mutants
We next investigated the behavior of these receptor constructs by taking a closer look at the temperaturedependence of their ligand binding (Figure 4 ). For this purpose the different cell clones were pre-equilibrated with w 3 HxBK at concentrations below their K d and then warmed up to the indicated temperatures. Mutant E177A showed an almost linear inverse correlation between increased temperature and reduction of binding, whereas both wt B 2 Rs responded only at temperatures above 258C with a strong decrease in binding. Construct Y305A displayed no reduction at all, but rather a maximum of binding at temperatures between 208C and 308C.
Fast dissociation at 378C requires addition of unlabeled BK or antagonist JE049
Besides the measurement of equilibrium dissociation constants at 378C, the inhibition of receptor sequestration also allowed the determination of the dissociation rate of w Figure 5A, B) . The dissociation did not depend on whether unbound w 3 Hxligand had been removed before by washing the cells or the incubation was continued in its presence. In the absence of unlabeled BK, however, the dissociation rate of w 3 HxBK was much slower and did not exceed significantly the rate that was caused by the drop in affinity ( Figure 5A ). The same effect was observed for the antagonist w 3 HxNPC 17731, yet with the difference that there was no change in binding when the cells were incubated at 378C in the continued presence of w 3 HxNPC 17731 ( Figure 5B) , demonstrating that the receptor affinity for the antagonist is clearly temperature-independent.
Effect of unlabeled ligand is probably due to prevention of reassociation of dissociated w
Hxligand
In Chinese hamster ovary (CHO) cells expressing high levels of B 2 R a negative cooperativity of the receptors resulting in faster dissociation rates with higher receptor occupancy has been reported (Pizard et al., 1998) . In order to differentiate between a fast dissociation rate caused by a negative cooperativity effect and one resulting from inhibition of rebinding of dissociated w HxBK for 90 min to reach equilibrium. Subsequently, the cells were washed with ice-cold PBS and placed in a water bath at 378C after addition of 1 mM BK in incubation buffer (378C). At the indicated times dissociation was stopped by washing the cells with ice-cold PBS and remaining surface binding was determined as described in the materials and methods section. Data are expressed as percentage of initial binding on ice and represent the mean"SEM from at least 3 independent experiments performed in duplicate. Abbreviations: wt B 2 R: wild-type B 2 bradykinin receptor; Y305A: B 2 bradykinin receptor mutant with a Tyr™Ala exchange at position 305; E177A: receptor mutant with a Glu™Ala exchange at position 177; E177A/Y305A: receptor double mutant with both amino acid exchanges. still far slower than the rate reached in the continued presence of 1 mM unlabeled BK (Figure 6 ). These data suggest that prevention of reassociation of w 3 HxBK plays an important role in the fast dissociation observed in the presence of unlabeled BK. This notion was further supported by the fact that the dissociation rate enhancing effect was not specific for the agonist BK but was also found with the antagonist JE049 ( Figure 5 ). Determination of the dissociation constants K d (see above) yields information on the system under equilibrium conditions but does not provide information on the kinetics of ligand association or dissociation. Therefore, we also determined the dissociation rates (in the presence of 1 mM BK) of the before mentioned mutants.
There was no difference in the dissociation rates between the high and the lower expressing B 2 R. They are therefore included as one construct in Figure 7 , and displayed a reduction of binding to approx. 25% of initial values on ice within 2 min at 378C. Mutant E177A dropped to 10% in less than a minute, whereas mutant Y305A revealed a very slow off-rate displaying approx. 75% of the initial binding after 2 min. The double mutant E177A/Y305A showed a dissociation rate slower than E177A but distinctly faster than the wt B 2 R. Thus, the dissociation rates reflected well the different equilibrium affinities determined at 378C after 30 min (cf. Table 1 ) and could be used to obtain a first estimate of the affinities of a receptor construct at 378C.
Discussion
One of the hallmarks of G protein-coupled receptors is the shift to lower affinity for agonists when guanine nucleotides such as GDP or GTP, or their poorly hydrolysable derivatives such as GTPgS, are added to membrane preparations at higher temperatures (Milligan, 2003) . In the ternary complex model the high affinity state represents the receptor in its active conformation stabilized by binding to the G protein, whereas the low affinity state represents the uncoupled receptor (Gether, 2000) . In the absence of guanine nucleotides, the ternary complex composed of agonist, G protein, and the receptor exhibiting high affinity is stable and dissociates only after addition of guanine nucleotides.
Despite being a hallmark of GPCRs the extent of the affinity shift can vary strongly from receptor to receptor. Whereas, for example, addition of guanine nucleotides to the b 2 -adrenergic receptor leads to a shift from 1.91=10 -9 to 1.8=10 -5 M, i.e. a shift of almost four orders of magnitude (Rasenick et al., 1994) , the B 2 R in crude membrane preparations of human foreskin fibroblasts exhibited only a shift from approximately 2 to 14 nM (Faussner and Roscher, 2000) . Moreover, in the AT 2 angiotensin receptor no shift at all is observed (Zhang and Pratt, 1996) . In this respect it has to be mentioned that also interactions with other cytosolic proteins, such as arrestins or small G proteins, have been reported to result in high affinity binding of receptors (Gurevich et al., 1997; Mitchell et al., 1998) .
In receptors that exhibit a large affinity shift this effect can be measured in competition experiments allowing a radioactive labeled antagonist to compete with increasing concentrations of unlabeled agonist. Addition of GTP then leads to a shift in the agonist displacement curve to the right side indicating the reduction in receptor affinity. For other receptors, such as the B 2 R, a right-hand shift in the order of one magnitude would be difficult to determine and would require a radiolabeled high affinity antagonist. The latter, however, is currently not commercially available for the B 2 R. In such a case, it is more convenient to measure the different affinities of the receptor for a radioactive agonist in the presence and absence of guanine nucleotides directly in crude membrane fractions at higher temperatures. However, especially with lysates of cells overexpressing the B 2 R, we found often a reduction in the affinity of the receptor when the temperature was raised from 48C to 378C. This effect was independent of an addition of exogenous GTP, thus reducing the measurable change (not shown). A reason for this behavior could be that due to the overexpression of the receptors not all receptors are coupled to a G protein and, therefore, can bind only with low affinity at 378C. Since the B 2 R on ice always exhibited only one binding site with high affinity this would suggest that coupling to a G protein is not required for high affinity binding at 48C. At this low temperature, weak interactions between side chains of the receptor and/or with membrane lipids might be strong enough to stabilize a conformation which may be maintained at 378C only by coupling to a G protein or other cytosolic proteins. If this hypothesis holds true, then the conformation of the receptors on ice, in partic-ular the conformation of its binding site, should be identical or very similar to the conformation of the coupled receptor at 378C. This hypothesis is strengthened by the reversibility of the shift through an additional incubation on ice. At this low temperature it is unlikely that the high affinity binding state is obtained by the receptor via recoupling to or recruiting of a G protein or other signaling proteins. However, the possibility cannot be excluded that the receptor -similar to its ability to bind extracellularly an agonist at 48C -is capable of interacting intracellularly with proteins at low temperatures. Further studies are therefore required to reach a final conclusion on this matter. The GTP-independent affinity reduction in membrane preparations at higher temperatures seems to be a common phenomenon of GPCRs, since most assays for a GTP effect on receptor affinity are conducted at temperatures below the physiological temperature of 378C, i.e. at 258C or 308C.
There was no significant difference between the K d values of B 2 R and mutant Y305A at 48C, although we have shown recently that the latter is precoupled to G protein G q/11 even in the absence of an agonist (Kalatskaya et al., 2004) . The high affinity of this mutant at 378C could at first sight be explained as a consequence of this increased coupling to G q/11 . Mutant Y305A is, however, able to stimulate inositol phosphate accumulation even better than the wt B 2 R (Kalatskaya et al., 2004) , and therefore also should repeatedly uncouple from G q/11 . For this reason it seems that this mutation results in a receptor conformation that is not only able to couple to G q/11 in the absence of an agonists but also persistently displays the high affinity binding that in the wt B 2 R would be induced only by the coupling to a G protein. Thus, this mutant apparently combines a propensity to precouple to G q/11 with permanent high affinity for the agonist BK.
By inhibiting receptor sequestration either through the use of a hyperosmolaric incubation buffer (0.5 M sucrose) or pretreating the cells with 100 mM PAO, we were able to measure a temperature-dependent shift in the receptor affinity in intact cells with good reproducibility. Phenylarsine oxide (PAO) acts on proteins by bridging vicinal sulfhydryl (SH)-groups of cysteins (Rokutan et al., 2000) . The bridging, however, is not required for inhibition of B 2 R internalization since monovalent N-methyl-maleimide could also block w 3 HxBK internalization. Because PAO does not change the affinity of the receptor at 48C, there should be no direct modification of the ligand binding site or the receptor. Furthermore, a cell impermeable SHgroup-modifying reagent (monobromotrimethyl-ammoniobimane bromide; de Lamirande and Gagnon, 1998) was not able to block receptor sequestration (not shown) suggesting that the SH-groups which must be modified for inhibition of receptor internalization are located inside the cell. Although PAO is often applied as a nonspecific tyrosine phosphatase inhibitor (Fletcher et al., 1993; Yingst et al., 2000) , the concentrations used for this purpose (-25 mM) were not sufficient to inhibit B 2 R internalization. For this reason it is unlikely that tyrosine phosphatases play a role in the prevention of receptor sequestration by PAO. The fact that besides treatment with PAO and 0.5 M sucrose also pretreatment with digitonin or N-methyl maleimide allowed the determination of the temperature-dependent affinity shift with similar results indicates that this shift is independent of the method used for inhibition of receptor sequestration and, therefore, represents an intrinsic property of the receptor itself.
The presented data suggest that the shift in the affinity of the B 2 R for w 3 HxBK is not caused by unspecific physical effects of the raise in incubation temperature, such as increased membrane fluidity, but involves the activation of the receptor by an agonist at temperatures higher than 208C (cf. Figure 4) . The affinity shift is also not cell type dependent, since it was also observed in CHO cells heterologously expressing the human B 2 R, as well as in human fibroblasts or in human embryonic lung fibroblasts WI-38 expressing naive B 2 kinin receptors (un published results). In addition, for the a 1 -adrenergic receptor it has been shown that the magnitude of a similar temperature shift determined in membranes for several (partial) agonists correlates well with their functional efficacy (Weiland et al., 1979) .
Moreover, we could show that the presence of a surplus of an unlabeled ligand is necessary for fast dissociation of a bound w 3 Hxligand (cf. Figures 5 and 6 ). Since this is similar for agonists and antagonist and works despite inhibition of receptor sequestration, the most likely explanation for this phenomenon is as follows: the receptors can still move into some half-closed compartments on the cell surface, where dissociated w 3 Hxligand remains close to the receptor and unlabeled ligand is necessary to prevent its reassociation. This behavior would be similar to that observed for the B 1 bradykinin receptor, which is not internalized after activation but translocates within in the plasma membrane to caveolaerelated rafts on the cell surface (Sabourin et al., 2002) .
In summary, using the B 2 bradykinin receptor as a model we have demonstrated in this report how inhibition of receptor sequestration by either 100 mM PAO or 0.5 M sucrose can be used to determine in intact cells the temperature-dependent affinity shift and ligand dissociation rates of G protein-coupled receptors or mutants thereof, thus providing information on the functional role of amino acids and domains in these receptors.
Materials and methods
Materials
Flp-In TREx-293 (HEK 293) cells were bought from Invitrogen (Groningen, Netherlands). w2,3-prolyl-3,4-3 Hxbradykinin (90 Ci/ mmol) and wprolyl-3,4-3 HxNPC17731 (48.5 Ci/mmol, no longer commercially available) were obtained from Perkin Elmer Life Sciences (Boston, USA). Bradykinin was purchased from Bachem (Heidelberg, Germany). The antagonist JE049 (formerly known as Hoe 140/Icatibant) was a generous gift from Jerini AG (Berlin, Germany). Roche (Mannheim, Germany) delivered Fugene. Poly-D-lysine hydrobromide, captopril, 1.10-phenanthroline, and bacitracin were purchased from Aldrich (Taufkirchen, Germany). Fetal calf serum, culture media, hygromycin B, and penicillin/streptomycin were delivered by PAA Laboratories (Cö lbe, Germany).
Expression system and cell culture
